Nascent Pharma Holdings Inc NASC
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.01–0.03
- Bid/Ask
- $0.01 / $0.02
- Shares Outstanding
- 90.22M
- Market Cap
- $1.61M
- Volume/Avg
- 600 / 44,848
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
Valuation
|
Metric
|
NASC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
NASC
Financial Strength
|
Metric
|
NASC
|
|---|---|
Quick Ratio | 0.12 |
Current Ratio | 0.14 |
Interest Coverage | −4.15 |
Quick Ratio
NASC
Profitability
|
Metric
|
NASC
|
|---|---|
Return on Assets (Normalized) | −63.28% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −43.46% |
Return on Assets
NASC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|M%@%l#& | LOCK|bYy@> | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|r!bk#L<$ | LOCK|YGg@ | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|J?^yvL | LOCK|Y?k | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|ZPMtGNtG | LOCK|qZ | $33B | |||
| Viatris Inc
VTRS
| LOCK|!QX<%^b | LOCK|%s | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|K?H | LOCK|#g | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|#DZ^V& | LOCK|b>c | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|>h>Xjb | LOCK|?tQ | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|CF!v%^Q | LOCK|pzQ&? | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|S%>m<G | LOCK|C? | $2B |
United States